Restoring circadian disrupted gut microbial metabolite rhythms with phytochemicals: a new avenue against metabolic disease.

Abstract

The global epidemic of metabolic diseases-encompassing obesity, type 2 diabetes mellitus (T2DM), non-alcoholic fatty liver disease (NAFLD), and cardiovascular disease-represents a defining public health challenge of our era. The traditional model of simple caloric excess vs. expenditure has proven insufficient, giving way to a paradigm that acknowledges complex interactions between genetics, environment, and lifestyle, mediated by intricate physiological systems. Among these, the host circadian timing system and the gut microbiome have ascended as pivotal, deeply intertwined regulators of metabolic homeostasis. The gut microbiome, far from a static collection of microbes, constitutes a dynamic and metabolically active community whose composition and, critically, its functional output exhibit profound and predictable diurnal oscillations. The host's circadian clocks regulate microbial rhythms primarily by controlling the daily cycle of feeding and fasting. Modern life induces circadian disruption (CD) through ubiquitous exposure to artificial light at night, shift work, social jet lag, and erratic eating patterns. It perturbs the rhythmic dynamics of the gut ecosystem, leading to a fundamental dysregulation in the temporal production of key microbial metabolites. These metabolites, including short-chain fatty acids, secondary bile acids (BAs), indoles and other tryptophan derivatives, function as indispensable chemical messengers that coordinate peripheral metabolism, immune responses, and energy homeostasis in a precise, time-of-day-dependent manner. Their desynchronization-manifesting as mistimed, deficient, or incessant signaling-directly instigates the core pathologies of metabolic disease: insulin resistance, adipocyte dysfunction, hepatic lipid accumulation, and chronic low-grade inflammation. This review synthesizes current evidence to delineate the multilevel mechanisms through which CD drives the dysregulation of gut microbiome metabolite rhythms and establishes the causal pathways linking this dysrhythmia to metabolic pathogenesis. Furthermore, we undertake a critical evaluation of the promising therapeutic potential of dietary phytochemicals-a diverse class encompassing polyphenols, glucosinolates, and prebiotic fibers-to act as chrono-therapeutic agents. Through their multifaceted capacity to remodel microbial ecology, calibrate microbial enzymatic output, and reinforce host circadian-metabolic coupling, phytochemicals present a novel, physiologically aligned, and sustainable dietary strategy for the prevention and management of metabolic disorders. We conclude by outlining key translational challenges and propose future research directions essential for harnessing the potential of the "clock-microbiome-metabolite" axis within the framework of precision nutrition and medicine.